Bupropion-induced somnambulism
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Whereas there are some case reports of bupropion‐induced vivid dreaming and nightmares, until now it has not been associated with somnambulism. A case is reported of a patient treated with bupropion as a smoking cessation medication, who developed somnambulism during nicotine withdrawal. Furthermore, the sleepwalking episodes were associated with eating behaviour. Amnesia was reported for all episodes. As, on one hand, bupropion is a noradrenergic and dopaminergic drug and nicotine withdrawal, on the other hand, is associated with alterations in monoaminergic functions, an interaction at the level of these neurotransmitters is suggested as the underlying mechanism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The appearance of SW has also been associated with other AD, like Bupropion [114,115], Mirtazapine [116], and Reboxetine [117].”
From Diagnosis and Management of NREM Sleep Parasomnias in Children and Adults (2023) · cites this paper as [114]
Citations
Cites
Signs and Symptoms of Tobacco Withdrawal
Hughes, J. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800030107013 · Cited by 1,669
Ohayon, M. M., Guilleminault, C., & Priest, R. G. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0413 · Cited by 381
Empirical Evidence and Psychotherapy: A Growing Scientific Base
GABBARD, G. O. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.1.1 · Cited by 348
Genesis and evolution of behavioral disorders: from infancy to early adult life
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.1.1 · Cited by 329
Hildebrand, B. E., Nomikos, G. G., Hertel, P., Schilström, B., & Svensson, T. H. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01135-9 · Cited by 200
Depression, sleep physiology, and antidepressant drugs
Winokur, A., Gary, K. A., Rodner, S., Rae-Red, C., Fernando, A. T., & Szuba, M. P. (2001) · Depression and Anxiety · doi:10.1002/da.1043 · Cited by 179
Schenck, C. H., Hurwitz, T. D., Bundlie, S. R., & Mahowald, M. W. (1991) · Sleep · doi:10.1093/sleep/14.5.419 · Cited by 175
Additional Categories of Sleep-Related Eating Disorders and the Current Status of Treatment
(1993) · Sleep · doi:10.1093/sleep/16.5.457 · Cited by 156
Rada, P., Jensen, K., & Hoebel, B. (2001) · Psychopharmacology · doi:10.1007/s002130100781 · Cited by 141
Tobacco withdrawal and nicotine replacement influence objective measures of sleep.
Wetter, D. W., Fiore, M. C., Baker, T. B., & Young, T. B. (1995) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.63.4.658 · Cited by 126
Cited by
Pressman, M. R. (2007) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2006.06.003 · Cited by 285
Parasomnias: An Updated Review
Howell, M. J. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0143-8 · Cited by 165
“Implicated agents have included antidepressants amitriptyline [28], bupropion [29, 30], paroxetine [31], and mirtazapine [32], the mood stabilizer, lithium [33, 34], the antipsychotics quetiapine [35] and olanzapine [36–38], the antihypertensive agent metoprolol [39], the anti-seizure agent topiramate [40], and the an…”
BackgroundMedication induced sleepwalking: A systematic review
Stallman, H. M., Kohler, M., & White, J. (2018) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2017.01.005 · Cited by 112
Htoo, A. K., Talwar, A., Feinsilver, S. H., & Greenberg, H. E. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.07.003 · Cited by 81
“[97] Khazaal Y, Krenz S, Zullino DF.”
BackgroundHughes, J. R. (2007) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2007.08.013 · Cited by 67
“This drug is a dopaminergic, central nervous system (CNS) stimulant [8].”
Background
Metadata
- Authors
- KHAZAAL, Y., KRENZ, S., & ZULLINO, D. F.
- Corresponding author
- KHAZAAL, YASSER
- Venue
- Addiction Biology
- Publisher
- Wiley
- Published
- 2003-09
- Volume
- 8
- Issue
- 3
- Pages
- 359-362
- ISSN
- 1355-6215 (ISSN-L)
- 1369-1600
- OpenAlex
- W1997641912
- Cited by
- 46
- References
- 31
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 1 · 2017: 2 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 6 · 2012: 2
- FWCI
- 1.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Addiction Biology (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Health Sciences › Medicine › Clinical Neurology › Restless Legs Syndrome Research
- Keywords
- bupropion, sleepwalking, nicotine withdrawal, smoking cessation, eating behaviour, amnesia, adverse drug reactions
- MeSH terms
- Adult, Amnesia, Humans, Male, Nicotine, Somnambulism, Substance Withdrawal Syndrome, Tobacco Use Disorder, Smoking Cessation, Bupropion, Dopamine Uptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bupropion-induced somnambulism. https://app.cochat.ai/papers/10.1080/13556210310001602284
- The paper
- KHAZAAL, Y., KRENZ, S., & ZULLINO, D. F. (2003). Bupropion-induced somnambulism. Addiction Biology. https://doi.org/10.1080/13556210310001602284
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.